登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《JMV，2月19日，The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-02-22

  • The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019

    Wenzheng Han Bin Quan Yi Guo Jun Zhang Yong Lu Gang Feng Qiwen Wu Fang Fang Long Cheng Nanlin Jiao Xiaoning Li Qing Chen

    First published:19 February 2020 https://doi.org/10.1002/jmv.25711

    Abstract

    A pneumonia outbreak caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which was first identified in Wuhan, present a major threat to public health since December 2019. There are more than 50,000 confirmed cases and 1300 dead cases worldwide for the past month or more, because of the occurrence of a highly contagious performance. Patients had clinical manifestations of fever, cough, shortness of breath, diarrhea, vomiting and so on. We herein report a case of SARS‐CoV‐2, describe the epidemic history, clinical diagnosis and the changes of clinical parameters during the combination therapy.

  • 原文来源：https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25711
97浏览量
原文链接
相关报告

  • 《JMV，2月7日，Evolving status of the 2019 novel coronavirus Infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring [Commentary/Review]》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-02-08
    • Evolving status of the 2019 novel coronavirus Infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring [Commentary/Review] Shu‐Yuan Xiao Yingjie Wu Huan Liu First published:07 February 2020 https://doi.org/10.1002/jmv.25702 Abstract The novel coronavirus (nCoV‐2019) outbreak in Wuhan, China has spread rapidly nationwide, with some cases occurring in other parts of the world. Although most patients present with mild febrile illness with patchy pulmonary inflammation, a significant portion develop severe acute respiratory distress syndrome (ARDS), with a current case fatality of 2.3‐3%. Diagnosis is based on clinical history and laboratory and chest radiographic findings, but confirmation currently relies on nucleic acid‐based assays. The latter are playing an important role in facilitating patient isolation, treatment and assessment of infectious activities. However, due to their limited capacity to handle an epidemic of the current scale and insufficient supply of assay kits, only a portion of suspected cases can be tested, leading to incompleteness and inaccuracy in updating new cases, as well as delayed diagnosis. Furthermore, there has not been enough time to assess specificity and sensitivity. Conventional serological assays, such as enzyme‐linked immunoassay (ELISA) for specific IgM and IgG antibodies, should offer a high‐throughput alternative, which allows for uniform tests for all suspected patients, and can facilitate more complete identification of infected cases and avoidance of unnecessary cross infection among unselected patients.
    190浏览量
    原文链接

  • 《Radiology，2月21日，Coronavirus Disease 2019 (COVID-19): A Perspective from China》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-02-22
    • Coronavirus Disease 2019 (COVID-19): A Perspective from China Zi Yue Zu*, Meng Di Jiang*, Peng Peng Xu, Wen Chen, Qian Qian Ni, Guang Ming Lu, Long Jiang Zhang * Drs Zu and Jiang had equal contributions to this work. Published Online:Feb 21 2020https://doi.org/10.1148/radiol.2020200490 Abstract In December 2019, an outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection occurred in Wuhan, Hubei Province, China and spread across China and beyond. On February 12, 2020, WHO officially named the disease caused by the novel coronavirus as Coronavirus Disease 2019 (COVID-19). Since most COVID-19 infected patients were diagnosed with pneumonia and characteristic CT imaging patterns, radiological examinations have become vital in early diagnosis and assessment of disease course. To date, CT findings have been recommended as major evidence for clinical diagnosis of COVID-19 in Hubei, China. This review focuses on the etiology, epidemiology, and clinical symptoms of COVID-19, while highlighting the role of chest CT in prevention and disease control.
    55浏览量
    原文链接